Prognostic importance of the platelet count 100 days post allogeneic bone marrow transplant

Bone Marrow Transplantation

Volumn 33, Issue 4, 2004, Pages 419-423

  Bolwell, B ^a   Pohlman, B ^a   Sobecks, R ^a   Andresen, S ^a   Brown, S ^a   Rybicki, L ^a   Wentling, V ^a   Kalaycio, M ^a  

^a TAUSSIG CANCER INSTITUTE   (United States)

Author keywords

Allogeneic BMT; Post transplant platelet count; Prognostic factors

Indexed keywords

ACICLOVIR; ANTIBIOTIC AGENT; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; ETOPOSIDE; GANCICLOVIR; GRANULOCYTE COLONY STIMULATING FACTOR; METHOTREXATE; PREDNISONE; THYMOCYTE ANTIBODY;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; BONE MARROW SUPPRESSION; CHRONIC GRANULOCYTIC LEUKEMIA; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FEBRILE NEUTROPENIA; FOLLOW UP; GRAFT REJECTION; HLA MATCHING; HODGKIN DISEASE; HUMAN; LIVING DONOR; MAJOR CLINICAL STUDY; MORTALITY; MULTIVARIATE ANALYSIS; MYELODYSPLASTIC SYNDROME; MYELOFIBROSIS; NEUTROPENIA; NONHODGKIN LYMPHOMA; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; REMISSION; RISK ASSESSMENT; RISK FACTOR; SIBLING; SURVIVAL; THROMBOCYTE COUNT;

ADOLESCENT; ADULT; BLOOD PLATELETS; BONE MARROW TRANSPLANTATION; FOLLOW-UP STUDIES; HEMATOLOGIC NEOPLASMS; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PLATELET COUNT; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TIME FACTORS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS;

EID: 1542269751     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704330     Document Type: Article

References (25)

1. Wingard JR, Piantadosi S, Vogelsang GB et al. Predictors of death from chronic graft-versus-host disease after bone marrow transplantation. Blood 1989; 74: 1428-1435.
2. Loughran TP, Sullivan K, Morton T et al. Value of day 100 screening studies for predicting the development of chronic graft-versus-host disease after allogeneic bone marrow transplantation. Blood 1990; 76: 228-234.
3. Wagner JL, Flowers MED, Longton G et al. The development of chronic graft-versus-host disease: an analysis of screening studies and the impact of corticosteroid use at 100 days after transplantation. Bone Marrow Transplant 1998; 22: 139-146.
4. First LR, Smith BR, Lipton J et al. Isolated thrombocytopenia after allogeneic bone marrow transplantation: existence of transient and chronic thrombocytopenic syndromes. Blood 1985: 65: 368-374.
5. Sullivan KM, Witherspoon RP, Storb R et al. Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation. Blood 1988; 72: 546-554.
6. Przepiorka D, Anderlini P, Saliba R et al. Chronic graft-versus-host disease after allogeneic blood stem cell transplantation. Blood 2001; 98: 1695-1700.
7. Wagner JL, Flowers M, Longton G et al. Use of screening studies to predict survival among patients who do not have chronic graft-versus-host disease at day 100 after bone marrow transplantation. Biol Blood Marrow Transplant 2001; 7: 239-240.
8. Zhang HP, Singer B. Recursive Partitioning in the Health Sciences. Springer: New York, NY, 1999.
9. Bortin MM, Gale RP, Humphrey EM et al. Bone marrow transplantation for acute myelogeneous leukemia: factors associated with early mortality. JAMA 1983; 249: 1166-1175.
10. Dinsmore R, Kirkpatrick D, Flomenberg N et al. Allogeneic bone marrow transplantation for patients with acute non-lymphocytic leukemia. Blood 1984; 63: 649-656.
11. McGlave PB, Haake RJ, Boström BC et al. Allogeneic bone marrow transplantation for acute nonlymphocytic leukemia in first remission. Blood 1988; 72: 1512-1517.
12. Copelan EA, Biggs JC, Thompson JM et al. Treatment for acute myelocytic leukemia with allogeneic bone marrow transplantation following preparation with BuCy2. Blood 1991; 78: 838-843.
13. Snyder DS, Chao NJ, Amylon MD et al. Fractionated total body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 99 patients with acute leukemia in first complete remission. Blood 1993; 82: 2920-2928.
14. Keating S, Suciu S, deWitte T et al. Prognostic factors of patients with acute myeloid leukemia (AML) allografted in first complete remission: an analysis of the EROTC-EIMEMA AML 8A trial. Bone Marrow Transplant 1996; 17: 993-1001.
15. Barrett AJ, Horowitz MM, Gale RP et al. Marrow transplantation for acute lymphoblastic leukemia: factors affecting relapse and survival. Blood 1989; 74: 862-871.
16. Gratwhol A, Hermans J, Niederwieser D et al. Bone marrow transplantation for chronic myelogenous leukemia: long-term results. Bone Marrow Transplant 1993; 12: 509-516.
17. Ringdén O, Horowitz MM, Gale RP, Biggs JC et al. Outcome after allogeneic bone marrow transplant for leukemia in older adults. JAMA 1993; 270: 57-60.
18. Cahn J-Y, Labopin M, Schattenberg A et al. Allogeneic bone marrow transplantation for acute leukemia in patients over the age of 40 years. Leukemia 1997; 11: 416-419.
19. Miller CB, Piantadosi S, Vogelsang GB et al. Impact of age on outcome of patients with cancer undergoing autologous bone marrow transplant. J Clin Oncol 1996; 14: 1327-1332.
20. Crawford SW, Fisher L. Predictive value of pulmonary function tests before marrow transplantation. Chest 1992; 101: 1257-1264.
21. Horak DA, Schmidt GM, Zaia JA et al. Pretransplant pulmonary function predicts cytomegalovirus-associated interstitial pneumonia following bone marrow transplantation. Chest 1992; 102: 1484-1490.
22. Gale RP, Bortin MM, van Bekkum DW et al. Risk factors for acute graft-versus-host disease. Br J Haematol 1987; 67: 397-406.
23. Weisdorf D, Hakke R, Blazar B et al. Risk factors for acute graft-versus-host disease in histocompatible donor bone marrow transplantation. Transplantation 1991; 51: 1197-1203.
24. Atkinson K, Horowitz MM, Gale RP et al. Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation. Blood 1990; 75: 2459-2464.
25. Carlens S, Ringdén O, Remberger M et al. Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysis. Bone Marrow Transplant 1998; 22: 755-761.